Entry and Submarket Concentration: Empirical Evidence from the Pharmaceutical Industry - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Review of Industrial Economics and Policy Année : 2013

Entry and Submarket Concentration: Empirical Evidence from the Pharmaceutical Industry

Résumé

The paper investigates the decisions of companies to enter new submarkets, analyzing the relationship between submarket concentration and entry through the explanatory power of submarkets. The relationship is analyzed both at the aggregate level for all countries and at the country-specific level using a pharmaceutical company dataset gathered in seven countries in the 1987-1998 period. A Bayesian panel probit model enables us to measure entry into a new submarket using the lagged dependent variable to incorporate potential state persistence. The results obtained at the submarket level indicate a negative correlation between concentration and entry by diversification, although previous literature at market level has indicated conflicting results for the same relationship.
Fichier principal
Vignette du fichier
eriep.6.3.pdf (1.54 Mo) Télécharger le fichier
Origine Accord explicite pour ce dépôt

Dates et versions

hal-03470102 , version 1 (08-12-2021)

Identifiants

  • HAL Id : hal-03470102 , version 1

Citer

Maria Letizia Giorgetti. Entry and Submarket Concentration: Empirical Evidence from the Pharmaceutical Industry. European Review of Industrial Economics and Policy , 2013, 6. ⟨hal-03470102⟩

Collections

ERIEP EPI-REVEL
18 Consultations
60 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More